Two doses of the SARS-CoV-2 BNT162b2 vaccine enhance antibody responses to variants in individuals with prior SARS-CoV-2 infection
RA Urbanowicz, T Tsoleridis, HJ Jackson… - Science translational …, 2021 - science.org
Understanding the impact of prior infection with severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) on the response to vaccination is a priority for responding to …
coronavirus 2 (SARS-CoV-2) on the response to vaccination is a priority for responding to …
Convalescent-phase sera and vaccine-elicited antibodies largely maintain neutralizing titer against global SARS-CoV-2 variant spikes
The increasing prevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-
2) variants with spike protein mutations raises concerns that antibodies elicited by natural …
2) variants with spike protein mutations raises concerns that antibodies elicited by natural …
[HTML][HTML] Infection-and vaccine-induced antibody binding and neutralization of the B. 1.351 SARS-CoV-2 variant
VV Edara, C Norwood, K Floyd, L Lai… - Cell host & …, 2021 - cell.com
The emergence of SARS-CoV-2 variants with mutations in the spike protein is raising
concerns about the efficacy of infection-or vaccine-induced antibodies. We compared …
concerns about the efficacy of infection-or vaccine-induced antibodies. We compared …
[HTML][HTML] SARS-CoV-2 variants show resistance to neutralization by many monoclonal and serum-derived polyclonal antibodies
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused the global
COVID-19 pandemic infecting more than 106 million people and causing 2.3 million deaths …
COVID-19 pandemic infecting more than 106 million people and causing 2.3 million deaths …
Neutralizing antibody activity against 21 SARS-CoV-2 variants in older adults vaccinated with BNT162b2
J Newman, N Thakur, TP Peacock, D Bialy… - Nature …, 2022 - nature.com
SARS-CoV-2 variants may threaten the effectiveness of vaccines and antivirals to mitigate
serious COVID-19 disease. This is of most concern in clinically vulnerable groups such as …
serious COVID-19 disease. This is of most concern in clinically vulnerable groups such as …
Sensitivity of SARS-CoV-2 B. 1.1. 7 to mRNA vaccine-elicited antibodies
DA Collier, A De Marco, IATM Ferreira, B Meng… - Nature, 2021 - nature.com
Transmission of SARS-CoV-2 is uncontrolled in many parts of the world; control is
compounded in some areas by the higher transmission potential of the B. 1.1. 7 variant …
compounded in some areas by the higher transmission potential of the B. 1.1. 7 variant …
Neutralizing antibodies to SARS‐CoV‐2 variants of concern including Delta and Omicron in subjects receiving mRNA‐1273, BNT162b2, and Ad26. COV2. S vaccines
SARS‐CoV‐2 vaccines have contributed to the control of COVID‐19 in some parts of the
world. However, the constant emergence of variants of concern (VOCs) challenges the …
world. However, the constant emergence of variants of concern (VOCs) challenges the …
Anatomy of Omicron BA. 1 and BA. 2 neutralizing antibodies in COVID-19 mRNA vaccinees
Abstract SARS-CoV-2 vaccines, administered to billions of people worldwide, mitigate the
effects of the COVID-19 pandemic, however little is known about the molecular basis of …
effects of the COVID-19 pandemic, however little is known about the molecular basis of …
[HTML][HTML] SARS-CoV-2 spike variants exhibit differential infectivity and neutralization resistance to convalescent or post-vaccination sera
A Kuzmina, Y Khalaila, O Voloshin, A Keren-Naus… - Cell host & …, 2021 - cell.com
Toward eradicating the COVID-19 pandemic, vaccines that induce high humoral and cellular
immune responses are essential. However, SARS-CoV-2 variants have begun to emerge …
immune responses are essential. However, SARS-CoV-2 variants have begun to emerge …
Crucial mutations of spike protein on SARS-CoV-2 evolved to variant strains escaping neutralization of convalescent plasmas and RBD-specific monoclonal …
C Ding, J He, X Zhang, C Jiang, Y Sun… - Frontiers in …, 2021 - frontiersin.org
Small number of SARS-CoV-2 epidemic lineages did not efficiently exhibit a neutralization
profile, while single amino acid mutation in the spike protein has not been confirmed in …
profile, while single amino acid mutation in the spike protein has not been confirmed in …